Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

PURPOSE: The optimal regimen intensity before allogeneic hematopoietic cell transplantation (HCT) is unknown. We hypothesized that lower treatment-related mortality (TRM) with reduced-intensity conditioning (RIC) would result in improved overall survival (OS) compared with myeloablative conditioning...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Scott, Bart L., Pasquini, Marcelo C., Logan, Brent R., Wu, Juan, Devine, Steven M., Porter, David L., Maziarz, Richard T., Warlick, Erica D., Fernandez, Hugo F., Alyea, Edwin P., Hamadani, Mehdi, Bashey, Asad, Giralt, Sergio, Geller, Nancy L., Leifer, Eric, Le-Rademacher, Jennifer, Mendizabal, Adam M., Horowitz, Mary M., Deeg, H. Joachim, Horwitz, Mitchell E.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2017
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455603/
https://ncbi.nlm.nih.gov/pubmed/28380315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.70.7091
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky